Efficacy of Leech therapy in Ringworm

Long Term Efficacy evaluation of Irsal-i-Alaq (Leech Therapy) in Qooba (Dermatophytosis)- A Randomised Standard Controlled Open Clinical Study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019781

Enrollment

Registered

2019-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

Intervention1: Leech therapy: Five sittings of leech therapy will be applied, with intervals of one week. Control Intervention1: Clotrimazole (1%) cream. : control group will apply Clotrimazole (1%)

Eligibility

Inclusion criteria

Inclusion criteria: Clinically Diagnosed patient of Qooba (Tinea corporis and Tinea pedis only, as leech application will be more feasible to these sites) Willing to participate in the study and follow the instructions

Exclusion criteria

Exclusion criteria: Uncontrolled Diabetes mellitus Bleeding disorder & anaemia Acute infection & septicaemia Patients on concomitant therapy Immuno-compromised patients

Design outcomes

Primary

Measure	Time frame
KOH smear Erythema and Scaling will be graded on a 4 point scale (0 Absent, 1 Mild, 2 Moderate and 3 Severe) Pruritus will be assessed on 10 cm long Visual Analogue Scale (VAS). Photographs of the affected site in a fixed location and controlled illumination.Timepoint: At Baseline, on 21st day and on 35th day. Follow ups on 35th day in person and over phone on 45th, 60th and 90th day.	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Abdul Azeez

national institute of unani medicine kottigepallya magadi main road, bengaluru

aafaris@gmail.com9035417278

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026